The Efficacy, Safety, and Cost Benefit of Olanzapine versus Aprepitant in Highly Emetogenic Chemotherapy: A Pilot Study from South India

Table 3

Patient demographics and baseline characteristics.

Patient characteristics	APD arm	OPD arm
Age in years (mean)	44.70 years	43.30 years
Sex
Male, (%)	15 (30%)	15 (30%)
Female, (%)	35 (70%)	35 (70%)
Type of cancer
Breast cancer	25 (50%)	26 (52%)
Lymphoma	9 (18%)	7 (14%)
Head and neck cancer	9 (18%)	10 (20%)
Osteosarcoma	5 (10%)	5 (10%)
Stomach cancer	2 (4%)	2 (4%)